XML 15 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
General - Basis of Presentation (Details 2) (USD $)
1 Months Ended 9 Months Ended 9 Months Ended 9 Months Ended
Jun. 30, 2011
Sep. 30, 2012
Long-Term Incentive Plan
Sep. 30, 2012
Long-Term Incentive Plan
Deferred stock units
Sep. 30, 2012
Long-Term Incentive Plan
Stock options
Y
installment
Sep. 30, 2011
Long-Term Incentive Plan
Stock options
Y
Sep. 30, 2012
Long-Term Incentive Plan
Stock, restricted stock awards and restricted stock units
Dec. 31, 2011
Long-Term Incentive Plan
Stock, restricted stock awards and restricted stock units
Sep. 30, 2012
Long-Term Incentive Plan
Restricted stock awards
Y
Details of stock benefit plans                
Increased in number of shares available for issuance   4,400,000            
Number of shares of common stock that may be issued under the Plan   9,666,666            
Maximum number of shares of common stock authorized to be issued under the Plan   14,066,666            
Stock split ratio 2              
Dividend in form of number of shares for each outstanding share of common stock 1              
Options to purchase common stock outstanding (in shares)       5,202,000        
Shares outstanding under the plan     2,000     1,772,000 548,000  
Shares available for future grant   3,104,000            
Number of equal annual installments over which options outstanding are cumulatively exercisable       4        
Stock-based compensation additional disclosures                
Weighted average grant date fair value of options granted (in dollars per share)       $ 16.13 $ 13.82      
Total intrinsic value of options exercised (in dollars)       $ 50,900,000 $ 5,000,000      
Fair value of options vested during the period (in dollars)       15,200,000 9,900,000      
Unrecognized compensation expense (in dollars)       29,700,000       13,400,000
Weighted-average period over which unrecognized compensation cost is expected to be recognized (in years)       3.1       0.7
Cash received from the exercise of stock option       29,900,000 6,100,000      
Options exercisable commencement period from grant date (in years)       1        
Term over which options are granted       P10Y        
Post-vesting cancellation rate used in valuation of options (as a percent)       0.00%        
Weighted-average assumptions used to estimate the fair value of stock options granted                
Risk-free interest rate (as a percent)       1.08% 1.64%      
Expected term (in years)       6.25 6.25      
Expected volatility (as a percent)       44.15% 43.69%      
Expected dividend yield (as a percent)       3.61% 0.66%      
Shares                
Options outstanding at the beginning of the period (in shares)       5,732,000        
Granted (in shares)       1,292,000        
Exercised (in shares)       (1,506,000)        
Forfeited (in shares)       (314,000)        
Expired (in shares)       (2,000)        
Options outstanding at the end of the period (in shares)       5,202,000        
Vested and expected to vest (in shares)       5,041,000        
Options exercisable (in shares)       802,000        
Weighted Avg. Exercise Price (in dollars per share)                
Options outstanding at the beginning of the period (in dollars per share)       $ 21.99        
Granted (in dollars per share)       $ 51.04        
Exercised (in dollars per share)       $ 19.86        
Forfeited (in dollars per share)       $ 28.42        
Expired (in dollars per share)       $ 31.31        
Options outstanding at the end of the period (in dollars per share)       $ 29.43        
Vested and expected to vest (in dollars per share)       $ 29.32        
Options exercisable (in dollars per share)       $ 23.20        
Weighted Avg. Remaining Contractual Term                
Options outstanding at the end of the period (in years)       8.51        
Vested and expected to vest (in years)       8.50        
Options exercisable (in years)       8.15        
Aggregate Intrinsic Value (in dollars)                
Options outstanding at the end of the period (in dollars)       152,787,000        
Vested and expected to vest (in dollars)       148,596,000        
Options exercisable (in dollars)       $ 28,555,000